Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / *W EXP 11/15/202
-
Total 13F shares
-
170,203
-
Share change
-
-37,408
-
Total reported value
-
$190,174
-
Price per share
-
$0.72
-
Number of holders
-
5
-
Value change
-
-$26,934
-
Number of buys
-
1
-
Number of sells
-
1
Institutional Holders of Medicus Pharma Ltd. - *W EXP 11/15/202 (MDCXW) as of Q3 2025
As of 30 Sep 2025,
Medicus Pharma Ltd. - *W EXP 11/15/202 (MDCXW) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
170,203 shares.
The largest 5 holders included
ARMISTICE CAPITAL, LLC, Private Advisor Group, LLC, Anson Funds Management LP, Warberg Asset Management LLC, and Connective Capital Management, LLC.
This page lists
5
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.